Literature DB >> 3220116

Prevention of ventricular fibrillation with magnesium sulfate.

G E Billman1, R S Hoskins.   

Abstract

Mongrel dogs with healed myocardial infarctions were given a 2 min coronary occlusion during an exercise test. The exercise plus ischemia test induced ventricular fibrillation in nine animals. One week later, the test was repeated after pretreatment with magnesium sulfate (100 mg/kg i.v.). Magnesium prevented ventricular fibrillation in seven of the nine animals without adverse side effects. Thus, magnesium may be useful in the management of ventricular fibrillation during ischemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3220116     DOI: 10.1016/0014-2999(88)90269-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Antiarrhythmic effect of magnesium sulfate against occlusion-induced arrhythmias and reperfusion-induced arrhythmias in anesthetized rats.

Authors:  S Komori; B Li; K Matsumura; M Takusagawa; S Sano; I Kohno; M Osada; T Sawanobori; T Ishihara; K Umetani; H Ijiri; K Tamura
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

Review 2.  [Value of K+ and Mg2+ in treatment of acute myocardial infarct].

Authors:  M Kunert; L Scheuble; H Stolzenburg; H Gülker
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

3.  Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction.

Authors:  C Roffe; S Fletcher; K L Woods
Journal:  Br Heart J       Date:  1994-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.